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Abstract
Several proteins that play key roles in cholesterol synthesis, regulation, trafficking and signaling are united by sharing the
phylogenetically conserved ‘sterol-sensing domain’ (SSD). The intracellular parasite Toxoplasma possesses at least one gene
coding for a protein containing the canonical SSD. We investigated the role of this protein to provide information on lipid
regulatory mechanisms in the parasite. The protein sequence predicts an uncharacterized Niemann-Pick, type C1-related
protein (NPC1) with significant identity to human NPC1, and it contains many residues implicated in human NPC disease.
We named this NPC1-related protein, TgNCR1. Mammalian NPC1 localizes to endo-lysosomes and promotes the movement
of sterols and sphingolipids across the membranes of these organelles. Miscoding patient mutations in NPC1 cause
overloading of these lipids in endo-lysosomes. TgNCR1, however, lacks endosomal targeting signals, and localizes to
flattened vesicles beneath the plasma membrane of Toxoplasma. When expressed in mammalian NPC1 mutant cells and
properly addressed to endo-lysosomes, TgNCR1 restores cholesterol and GM1 clearance from these organelles. To clarify the
role of TgNCR1 in the parasite, we genetically disrupted NCR1; mutant parasites were viable. Quantitative lipidomic analyses
on the DNCR1 strain reveal normal cholesterol levels but an overaccumulation of several species of cholesteryl esters,
sphingomyelins and ceramides. DNCR1 parasites are also characterized by abundant storage lipid bodies and long
membranous tubules derived from their parasitophorous vacuoles. Interestingly, these mutants can generate multiple
daughters per single mother cell at high frequencies, allowing fast replication in vitro, and they are slightly more virulent in
mice than the parental strain. These data suggest that the DNCR1 strain has lost the ability to control the intracellular levels
of several lipids, which subsequently results in the stimulation of lipid storage, membrane biosynthesis and parasite division.
Based on these observations, we ascribe a role for TgNCR1 in lipid homeostasis in Toxoplasma.
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Introduction
Toxoplasma gondii is an obligate intracellular parasite that resides
in a unique vacuole formed in the cytoplasm of mammalian cells
during invasion. The parasitophorous vacuole (PV) of Toxoplasma
protects the parasite from hostile cytosolic innate immune-
surveillance pathways and potent inflammatory signaling cascades.
Although separated from the nutrient-rich cytosol by the PV
membrane, the parasite has nevertheless evolved efficient
strategies to co-opt multiple host cellular pathways and host
organelles, to acquire essential nutrients and fuel its growth. The
parasite expresses many surface transporters that mediate the
internalization of host molecules [1]. T. gondii contains large
amounts of cholesterol that it scavenges from plasma low-density
lipoproteins (LDL) after processing in host endocytic compart-
ments [2]. Interference with LDL endocytosis or cholesterol egress
from host lysosomes arrests parasite development. We demon-
strated that Toxoplasma can sequester nutrient-filled host lysosomes
within invaginations of the PV membrane, which allows access to
cholesterol supplied by the host endocytic network [3]. Cholesterol
incorporation into the parasite is abolished after treatment with
various proteases [4], and we have recently identified a transport
system of cholesterol to the parasite involving parasite ABCG
proteins [5]. Although much is known about host cholesterol
delivery to Toxoplasma, very little is known about the regulatory
mechanisms and trafficking routes of cholesterol (and other lipids)
within the parasite. We have reported a role for a D-bifunctional
protein containing two sterol-carrier protein-2 domains in
promoting the circulation of phospholipids, cholesterol and fatty
acids between parasite organelles and the plasma membrane in T.
gondii [6].
In higher organisms, intracellular cholesterol transport is a
fundamental process required for cell division, growth and
differentiation. The distribution of cholesterol in different
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vesicle-mediated interorganelle transport and protein-mediated
monomeric transfer through the aqueous cytosol [7,8]. Among the
cholesterol-binding proteins, the Niemann-Pick C (NPC) proteins,
NPC1 and NPC2, are required for cholesterol export from
endocytic organelles [9]. Loss of function of either of these proteins
causes the sequestration of LDL-derived cholesterol and other
lipids in these organelles and leads to a progressive neurodegen-
erative disorder: the NPC disease [10]. NPC1 is a multispanning
transmembrane protein residing predominantly in the limiting
membrane of late endosomes/lysosomes while NPC2 is a soluble
lysosomal protein [11,12]. Both proteins operate in the trafficking
of cholesterol in the endo-lysosomal vesicle system; cholesterol
liberated from LDL is first bound to NPC2 that then hands off the
lipid to NPC1 that expels cholesterol out of the lysosomal
compartment [13,14]. NPC2 has a hydrophobic interior contain-
ing small cavities that can accommodate the steroid core while
NPC1 has a high affinity binding domain to cholesterol at the N-
terminus, called the sterol-binding domain (SBD). In addition,
NPC1 has five to six transmembrane regions constituting the
putative ‘sterol-sensing domain’ (SSD) that is common to many
proteins that have key roles in cholesterol homeostasis or
cholesterol-linked signaling [15]. However, while several potential
interaction surfaces of the NPC proteins have been identified, the
molecular mechanism of NPC interaction to transfer cholesterol
remains still elusive.
NPC1 and NPC2 are conserved throughout much of eukaryotic
evolution [16]. An authentic NPC1 ortholog appears in fungi,
worms, insects, slime molds, plants and all mammals. Within the
genome of most multicellular organisms, the NPC1 gene is
represented at least twice. The retention of NPC1 genes
throughout eukaryotic evolution permits the identification of
conserved sequence motifs that include the SSD [15]. In addition
to NPC1, 3-hydroxy-3-methylglutaryl CoA reductase (HMGCoA
reductase, the key enzyme of the mevalonate pathway producing
sterols), SCAP [the sterol regulatory element-binding protein
(SREBP)-cleavage activating protein] (a regulator of the sterol-
dependent transcription of cholesterol biosynthetic genes), 7-
dehydrocholesterol reductase (an enzyme involved in cholesterol
biosynthesis), Patched (a tumor suppressor involved in the signal
transduction cascade mediated by the cholesterol-modified
morphogen Hedgehog), Dispatched (a protein that facilitates the
secretion of Hedgehog) and the Patched-related protein (a protein
closely related in sequence and predicted topology to Patched)
share a SSD. Mutations in the SSD of these proteins in
mammalian cells render insensitivity not only to sterols but also
to other lipids such as oxysterols, fatty acids, sphingolipids and
phospholipids, suggesting that the SSD is a motif for membrane
anchorage that can sense and respond to various agents that
perturb membranes [17–20]. In yeast, a dominant mutation in the
putative SSD of NCR1, a homolog of NPC1, confers resistance to
inhibitors of inositophosphorylceramide and accumulation of
complex sphingolipids, but no defect in sterol metabolism,
pointing to a primary role of yeast NCR1 in sphingolipid recycling
instead of sterol homeostasis [21].
To gain more insight into the key cellular pathways that govern
lipids, e.g., cholesterol movement within T. gondii, we have
characterized a parasite protein harboring a canonical SSD. This
protein is a close relative of human NPC1, and we named it
TgNCR1. When targeted to mammalian endo-lysosomes,
TgNCR1 restores lipid trafficking from these organelles in
mammalian NPC1 mutant cells. We generated a parasite cell line
lacking NPC1 that is viable. The mutant parasites exhibit
perturbations in their content in lipids, e.g. cholesteryl esters and
sphingolipids, but not in free cholesterol. These alterations are
reflected by the amassing of large lipid bodies in the parasite
cytoplasm, and the stimulation of membrane biosynthesis and
parasite replication. This suggests the involvement of TgNCR1 in
monitoring the status of various lipids in Toxoplasma, a regulatory
function likely important for proper parasite growth.
Results
Cloning and molecular characterization of a Toxoplasma
protein that harbors an archetypal ‘sterol sensing-like
domain’ and shares identity with human NPC1
To identify parasite proteins involved in cholesterol homeostasis
in T. gondii, we searched for sequence homology to the sterol-
sensing domain (SSD) in the Toxoplasma genome database
(ToxoDB.org). A gene coding for a transmembrane polypeptide
containing a sterol-sensing-like domain, annotated ‘Patched
transmembrane domain-containing protein’ was retrieved
(TGME49_090870; location on chromosome IX). Another gene
with the same annotation was also present but its expression level
was predicted to be very low (TGME49_120500; location on
chromosome IV). As expected, no genes with homologous
sequences to sterol biosynthetic enzymes, HMGCoA reductase
and 7-dehydrocholesterol reductase, could be identified from the
genomic database of T. gondii. The regulatory SREBP-SCAP
machinery and the Patched/Hedgehog system are also missing
from the parasite genome. The ORF of TGME49_090870 was
amplified by PCR from a sporozoite cDNA library; it is 3,534
nucleotides long, consists of 6 exons and encodes a polypeptide of
1,178 amino acids, predicting a protein of 130.6-kDa (Figure S1).
A parallel search of the Eukaryotic Pathogens Database Resources
(EuPathDB.org) for sequence homology to TGME49_090870
using Jalview 2.6.1 [22] revealed the presence of one or two
versions of NPC1-related protein in several apicomplexan
parasites including Neospora caninum, Cryptosporidium sp. and
Author Summary
The intracellular parasite Toxoplasma is auxotrophic for
several lipids that it scavenges from host organelles.
Several studies focused on deciphering the pathways
implicated in host lipid delivery to the parasite, but less
effort has been devoted to understand how lipids are
regulated in Toxoplasma. The ‘sterol-sensing domain’ (SSD)
is conserved across phyla and present in several mem-
brane proteins involved in cholesterol homeostasis, cell
signaling and cytokinesis. We studied the role of a SSD-
containing protein in Toxoplasma which shows significant
similarity with Niemann-Pick type C1 proteins (NPC1).
Human NPC disease is typified by lysosomal accumulation
of cholesterol and sphingolipids. Expression of the parasite
NPC1-related protein (named TgNCR1) in mammalian
NPC1 mutant cells suppresses lipid accumulation in
lysosomes. However, Toxoplasma never internalizes host
cholesterol into lysosomes, which predicts a function for
TgNCR1 unrelated to exogenous sterol transport. Indeed,
genomic deletion of NCR1 does not result in abnormal
levels of cholesterol in the parasites but in the over-
accumulation of cholesteryl esters and sphingolipids.
TgNCR1-deficient parasites form abundant storage lipid
bodies and multiple parasites per cycle of division. This
suggests that TgNCR1 functions in monitoring the levels of
various lipids within Toxoplasma, which in turn impacts the
parasite’s lipid homeostasis and growth rate.
Role of NCR1 for Lipid Regulation in Toxoplasma
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Babesia (Figure S2).
Analysis of the deduced amino acid sequence of the sterol
sensing-like domain of TGME49_090870 reveals high similarity to
the SSD of the members of the cholesterol-sensing protein family
(Figure 1A). The parasite sterol sensing-like domain encompasses
180 amino acids and is organized into five membrane spanning a-
helices (Figure S3). This domain shares 31% identity and 51%
similarity with the SSD of human NPC1. Interestingly, the sterol
sensing-like domain in the Toxoplasma protein contains many
residues implicated in the human NPC disease [23–26]. Of the
miscoding mutations identified in the SSD of human NPC1 that
are responsible for severe biochemical defects in patients, seven
amino acids (70%) are identical between the parasite protein and
human NPC1 (Y-634, G-660, G-673, P-691, D-700, D-786 and
R-789). Figure 1A highlights the SSD containing a number of
conserved amino acids that have been implicated in the NPC
disease and that are present in the Toxoplasma protein.
In addition to a putative SSD, TGME49_090870 has multiple
membrane spanning domains and two Patched Homology
Domains (PHD) that typify the NPC family (Figure 1B). The
parasite sequence does not possess endosomal targeting signals
such as a C-terminal di-Leu motif [27], probably due to the lack of
endocytic compartments in the parasite. The N-terminal sequence
of human NPC1 harbors the sterol-binding domain (SBD) on
luminal loop-1 that is known to interact with cholesterol and
oxysterols with high affinity [28,29]. Sequence alignment of the N-
terminal ends of TGME49_090870 and human NPC1 encom-
passing the SBD reveals the presence of 35 identical residues
(22%), which suggests that the N-terminus of the parasite protein
may have potential sterol binding activity (Figure 1C). Moreover,
several conserved Pro and Gly residues present in the parasite
amino-terminal sequence are critical residues whose substitutions
correspond to naturally occurring mutations in patients with NPC
disease. At the protein level, the parasite full-length sequence has
37% identity and 61% similarity with human NPC1; 61 of the
functionally important residues (59%) for the sterol transfer
function are present, and 47 of those are identical to human
NPC1. Based on these observations, we therefore renamed the
protein, TgNCR1 (for NPC-related gene 1). A schematic
representation of the topology of TgNCR1 and human NPC1
shown in Figure 2A highlights their structural similarities.
Expression of TgNCR1 corrects the cholesterol-trafficking
defect in NPC1 mutant cells
To test the functional equivalence of TgNCR1 and mammalian
NPC1, we planned to express TgNCR1 in a CHO cell line lacking
functional NPC1 and examine the potential ability of the parasite
protein to restore NPC1 activity in the mutant cells, namely the
abatement of lipid accumulation in endo-lysosomes. However, as
Toxoplasma does not possess an endocytic membranous system
involved in the internalization of extracellular cholesterol,
TgNCR1 does not contain any targeting information for endocytic
organelles as found on human NPC1. We first analyzed the
intracellular localization of TgNCR1 when ectopically expressed
in mammalian cells. CHO cells were transfected with pHA-
TgNCR1 and immunolabeled with antibodies against HA
(Figure 2B). A fluorescence pattern corresponding to cortical and
perinuclear ER was discernible. Expectedly, no staining was
observed on endo-lysosomal compartments. We therefore decided
to engineer a chimeric protein to correctly address TgNCR1 to
endo-lysosomes in mammalian cells. Mammalian NPC1 localiza-
tion to endo-lysosomes is mediated by several COOH-terminal
motifs [26]. We constructed a hybrid protein in which the last 64
residues of human NPC1 that encompass most of the functional
endosomal targeting motifs (hNPC11214-1278) were fused to
TgNCR1 lacking its last 78 amino acids (TgNCR1D1101-1178)a s
schematized in Figure 2A. A myc tag was introduced at the N-
terminus of the chimeric protein designated myc-TgNCR1-
hNPC1. The expression construct was transfected into CHO cells
for double immunofluorescence assays (IFA) using antibodies
against myc and various markers of endosomes or lysosomes
(Figure 2C). Results show that the TgNCR1-hNPC1 fusion
protein largely localized to structures positively labeled for
EEA1, LAMP1 or LysoTracker, indicating delivery of the
exogenous protein to endocytic organelles.
We used the somatic 2-2 mutant of CHO cells as a model of
NPC1 mutant cells. These cells are characterized by the excessive
accumulation of lipids including cholesterol in endocytic compart-
ments [30]. We confirmed this phenotype by staining the 2-2
mutant cells with filipin, a fluorescent compound that binds to the
b-hydroxyl group of sterols, and data revealed enlarged, filipin-
positive structures corresponding to perinuclear lysosomes (Figure
S4A). Our ultrastructural observations of sterol-overloaded
lysosomes in filipin-treated 2-2 mutant cells illustrated the
corrugated aspect of membranes as a result of the formation of
sterol-filipin complexes (Figure S4B). The 2-2 mutant cells were
transfected with pmyc-TgNCR1-hNPC1 to assess sterol transport
by filipin staining and fluorescence microscopy. We first confirmed
the localization of the TgNCR1-hNPC1 fusion protein to
perinuclear structures in 2-2 mutant cells (Figure 3A). Expression
of the TgNCR1-hNPC1 fusion protein largely restored cholesterol
clearance from endo-lysosomes (Figure 3B) as quantified by a ,4-
fold reduction in filipin intensity levels in endo-lysosomes of the
transfected cells with TgNCR1-hNPC1 compared to mock-
transfected cells (Figure 3C). Fluorescence levels in mutant cells
expressing TgNCR1-hNPC1 were not significantly different from
those associated with endo-lysosomes in wild-type cells (Figure 3C).
Thin layer chromatography (TLC) analysis of a neutral lipid
fraction of cellular extracts of TgNCR1-hNPC1-expressing
mutant cells confirmed that the levels of free cholesterol have
returned to normal (Figure 3D). No change has been observed in
the levels of esters of cholesterol between wild-type cells, NPC1
mutant cells and mutant cells expressing TgNCR1-hNPC1 (Figure
S5). The 2-2 mutant cells expressing TgNCR1 did not show any
decrease in endo-lysosomal filipin staining, in accordance to the
mislocalization of TgNCR1 in the ER. Negative controls for these
experiments included mutant cells transfected with a truncated
construct containing a short sequence of the C-terminus of
TgNCR1 (from residues 978 to 1100) combined with the C-
terminal end of hNPC1 containing the endosomal targeting motifs
(Tr.TgNCR1-hNPC1). This chimeric construct localized both to
endocytic compartments and the ER, and the filipin fluorescence
levels in these cells were similar to those in TgNCR1-expressing
cells.
The subcellular accumulation of sphingolipids, particularly
gangliosides (e.g., GM1), is another characteristic of the NPC1
syndrome [31]. TLC analysis of an acidic lipid fraction from
cellular extracts confirmed that these 2-2 mutant cells contained
high levels of GM1, whereas in CHO wild-type cells the levels of
this lipid were undetectable (Figure 3D). TgNCR1-hNPC1
expression in mutant cells caused an obvious decrease in the
levels of GM1 compared to NPC1 mutant cells, and quantitative
measurement indicated a reversion of the GM1 accumulation by
,6-fold.
Altogether, these results suggest that, when provided with the
correct localization motif for endocytic compartments, the
TgNCR1constructs functions in a similar way as human NPC1
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PLoS Pathogens | www.plospathogens.org 3 December 2011 | Volume 7 | Issue 12 | e1002410Figure 1. Characteristic features of the predicted sequence of TGME49_090870 displaying a sterol-sensing-like domain and some
conserved critical motifs of the NPC1 family. A. Multiple sequence alignment of the predicted SSD of TGME49_090870 with the human
sequences of NPC1 (GI:38649260), Patched (GI:1381236) and SCAP (GI:66932902) using the CLUSTALW program, revealing the presence of many
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organelles, which indicates a conserved activity of the two proteins.
TgNCR1 localizes to the inner membrane complex in the
parasite
Our data showed that in mammalian cells, the parasite and
human NPC1 are interchangeable with respect to LDL-cholesterol
transport from endocytic compartments. However, Toxoplasma
never internalizes host cholesterol into endo-lysosomes, which
predicts a function for TgNCR1 unrelated to exogenous sterol
transport. This raises an intriguing issue about the biochemical
function of TgNCR1 in T. gondii. As the first step towards
understanding the molecular function of TgNCR1 in the parasite,
we decided to examine its intracellular localization. For this
purpose, a recombinant peptide corresponding to residues 162 to
501 of TgNCR1 was produced in E. coli to generate polyclonal
antibodies in rabbits (Figure S6). Using anti-TgNCR1162-501
antibodies, immunofluorescence of intracellular wild-type parasites
showed a diffuse peripheral staining along the parasite body,
which seemed to be excluded from the apical and basal extremities
of the parasite (Figure S7). Despite several attempts to purify these
antibodies, a high level of fluorescence background remained both
on the parasites and in host cells, which precluded the use of these
antibodies for in-depth morphological studies.
To circumvent this issue and have a better resolution of the
TgNCR1 localization, we created a stable line of the parasite
expressing, under the tubulin promoter, TgNCR1 with a HA tag
at the N-terminus. Lysates of transgenic parasites were resolved in
SDS-PAGE and immunoblot analysis using anti-HA antibodies,
confirming the expression of exogenous HA-TgNCR1, which
migrated as a single band at ,140-kDa (Figure 4A). Immunoflu-
orescence of intracellular HA-TgNCR1-expressing T. gondii
showed a peripheral staining along the parasite body as observed
on wild-type parasites labeled with anti-TgNCR1162-501 antibodies
(Figure 4B). The apical and basal extremities of the parasite
transfectants clearly excluded the staining, and this pattern is
reminiscent of resident proteins of the inner membrane complex
(IMC). EM observations reveal that the IMC is a continuous
patchwork of flattened vesicular cisternae located beneath the
plasma membrane and overlying the cytoskeletal network [32,33].
The IMC arises from vesicles derived from the secretory pathway
which flatten during parasite maturation to form large membra-
nous sheets that envelop the parasite, leaving only a small gap at
both parasite ends. TgNCR1 localization was further confirmed
by immunoEM staining showing gold particles on the IMC
(Figure 4C). Toxoplasma divides by endodyogeny, a mode of
replication in which two daughter cells are produced within an
intact mother parasite [34,35]. A critical step in building daughter
cells is the construction of their IMC, which forms a bud into
which replicated organelles are packaged. Figure 4D reveals
TgNCR1 labeling on the cone-shaped cistern forming nascent
IMC, indicating the association of the protein with the daughter
parasites at the onset of their formation. Immunogold staining
confirmed an association of TgNCR1 with the IMC of nascent
parasites (Figure 4E). Interestingly, the presence of gold particles
was also visible on vesicles adjacent to the IMC (Figure 4F).
Quantitative distribution of gold particles on various parasite
compartments indicated that more than 80% of the gold staining
was associated with both the IMC and vesicles, while the ER
counted for 8% of the gold labeling density (Figure 4G). Finally to
corroborate this IMC localization, we engineered two other
constructs: TgNCR1, under the NTPase promoter, tagged at its
N-terminus with the HA epitope and TgNCR1, under the tubulin
promoter, tagged at its C-terminus with the HA epitope. Parasites
were transiently transfected with each construct, and the original
localization of TgNCR1 on the IMC was confirmed in these
transgenic parasites expressing HA-TgNCR and TgNCR1-HA
(Figure S8).
Parasites expressing dominant negative mutants of
TgNCR1 have no striking phenotype
As the second step towards clarifying the role of TgNCR1 in the
parasite, we expressed in the wild-type T. gondii four different
dominant negative mutants derived from HA epitope-
tagged TgNCR1: HA-TgNCR1D571N, HA-TgNCR1P913A, HA-
TgNCR1I957T and HA-TgNCR1L1100V. These mutants are
predicted to be dominant negative based on identified mutations
in NPC1 patients [24–26]. When transiently transfected in the
parasite for 16 h to 24 h, these constructs produced a signal that
localized to the IMC/ER. The four dominant negative mutants
were viable and gave no unusual phenotype, such as the abnormal
accumulation of lipids based on TLC analysis, which precludes
further functional studies (data not shown). It is possible that
dominant negative mutants have lower expression levels than
TgNCR1 wild-type protein, which renders the dominant-negative
effect silent. Another possibility could be that the time-course for
lipid accumulation takes longer than 24 h before giving a clear
phenotype. While the expression level of the mutant proteins or
the timing of the lipid accumulation phenotype may effect the lack
of phenotype, it is also plausible that the amino acids mutated in
the TgNCR1 sequence are not critical for its function in the
parasite, which may be viewed as evidence that TgNCR1 plays
distinct roles from human NPC1.
Depletion of NCR1 does not affect parasite replication
As the third approach to study the function of TgNCR1 in T.
gondii, we focused on genetically disrupting NCR1 using a fusion
PCR-based method to replace NCR1 in the parasite genome with a
selectable HXGPRT marker. Clones were tested by PCR and
Southern blotting for the absence of NCR1 and the presence of a
single copy of the HXGPRT cassette (Figure 5 and Figure S9).
Clones lacking NCR1 were obtained, demonstrating that TgNCR1
was not necessary for the in vitro propagation of T. gondii.I n
fibroblasts, the DNCR1 strain formed large vacuoles that
associated with host organelles, e.g., mitochondrion, as observed
for wild-type parasites (Figure S10). The knockout parasites were
organized in rosettes. During normal endodyogeny, the cytoplasm
of the mother parasite is equally distributed between the daughter
cells; a cleavage furrow is initiated at the anterior pole and extends
between the daughters throughout the mother cell, leaving only a
residual body at the posterior end connecting the two daughters.
The residual body contains mother cell components that are not
conserved identical (black boxes) and similar (grey boxes) amino acids in these proteins. Asterisks show some amino acids that are critical for SSD
function and responsible for the human NPC disease if mutated or missing. B. Schematic of the domain structure of TGME49_090870 (obtained after
cloning), human NPC1 and yeast Ncr1p (GI:259150148), showing the position of the predicted SSD, PHD (Patched Homology Domain) and
transmembrane domains (in black). The sequence of TGME49_090870 lacks the Leu zipper present in the high affinity sterol-binding domain (SBD)
and the endosomal targeting motifs identified in the human NPC1 sequence. C. Sequence alignment of the predicted N-terminal sequences of
TGME49_090870 and human NPC1 comprising the SBD, showing a high proportion of identical amino acids.
doi:10.1371/journal.ppat.1002410.g001
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PLoS Pathogens | www.plospathogens.org 5 December 2011 | Volume 7 | Issue 12 | e1002410Figure 2. Localization of TgNCR1 in mammalian cells after transfection. A. Schematic representation of the NPC1 constructs: human NPC1
(hNPC1) showing the endosomal targeting motif in purple, full lengthTgNCR1 or TgNCR1 modified in which the last 78 amino acids have been
deleted and replaced by the last 64 amino acids of hNPC1, designed TgNCRC1-hNPC1. B–C. Fluorescence microscopy of CHO cells expressing the
TgNCR1 constructs with either HA or myc tags at the N-terminus. After transfection of pHA-TgNCR1 in B or pmyc-TgNCR1-hNPC1 in C, cells were fixed
and immunostained with anti-HA or anti-myc antibodies to localize the TgNCR1 constructs. A pattern corresponding to the ER was identified for
TgNCR1 while TgNCR1-hNPC1 was mainly expressed in endo-lysosomal compartments, which were identified by immunostaining of endogenous
markers (EEA1, an early endosome-associated protein or LAMP1, a lysosomal-associated membrane protein), or by labeling with Lyso-Tracker (LysoT).
In blue, DAPI staining; n, nucleus.
doi:10.1371/journal.ppat.1002410.g002
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PLoS Pathogens | www.plospathogens.org 6 December 2011 | Volume 7 | Issue 12 | e1002410Figure 3. Decrease in sterol accumulation in NPC1 mutant cells expressing TgNCR1-hNPC1. A. Immunofluorescence microscopy of 2-2
mutant CHO cells expressing TgNCR1-hNPC1. 2-2 mutant cells have been transiently transfected with pmyc-TgNCR1-hNPC1, fixed and immunostained
using anti-myc antibodies. Myc-TgNCR1-hNPC1 shows staining in perinuclear lysosomes. B. Filipin staining of 2-2 mutant cells expressing TgNCR1-
hNPC1, TgNCR1 full-length or a truncated version of the C-terminal end of TgNCR1-hNPC1 (tr. TgNCR1-hNPC1). After transient transfection with
pmyc-TgNCR1-hNPC1,p myc-TgNCR1 or pmyc-tr.TgNCR1-hNPC1, cells were stained with anti-myc antibodies to detect tagged protein expression and
with filipin to visualize sterols in transfected cells. Representative pictures are shown for each construct. Only the TgNCR1 construct that localizes to
endo-lysosomes (TgNCR1-hNPC1) was able to facilitate cholesterol egress from these organelles. C. Quantitative measurement of filipin fluorescence
levels associated with 2-2 mutant cells transfected with the indicated TgNCR1 constructs in comparison to wild-type CHO cells. Fluorescence intensity
collected on 45–50 endo-lysosomes per condition was expressed as arbitrary values. Error bars indicate SEM, n=3 (*, P,0.01 comparing TgNCR1-
hNPC1-transfected cells with vector alone). D. TLC analysis of neutral (upper; FC, free cholesterol) and acidic (lower) fractions of cellular lipid extracts
from CHO cells: wild-type or mutant transfected with either TgNCR1-hNPC1 or vector only. Positions of the standard lipids are indicated (left). After
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disappears after the completion of parasite division. Interestingly,
we observed that the progeny of TgNCR1-deficient parasites staid
mostly connected by their posterior ends to a common and
enlarged residual body. Similar prominent residual bodies were
also apparent in light microscope images. Disruption of TgNCR1
did not result in any obvious defect in parasite invasion or egress
(data not shown).
The growth rate of the DNCR1 strain in fibroblasts was
quantified by uracil incorporation assays. Compared to the
parental strain the (DKu80DHXGPRT or DK80), the DNCR1
strain incorporated significantly higher amounts of uracil (1.4-fold
increase) at 16 h, 24 h and 48 h p.i. (Figure 6A). To verify the
specificity of the mutant phenotype, we genetically complemented
the DNCR1 strain with TgNCR1. TgNCR1-complemented clones
were verified by PCR analyses (Figure S11). Values of uracil
incorporation were comparable in the complemented and parental
strains, corresponding to 2,3926504 cpm and 2,6936134 cpm,
respectively, which indicates that the uracil incorporation defect of
the DNCR1 strain was due to the deletion of NCR1.
TgNCR1-deficient parasites are insensitive to excess
cholesterol in the medium and contain normal amount
of free cholesterol
We previously reported that Toxoplasma growth is directly
dependent upon exogenously supplied cholesterol [2]. Mammalian
NPC1 has a primordial function in exogenous sterol distribution
throughout the cell [36]. TgNCR1-deficient parasites were then
exposed to excess amounts of LDL-cholesterol to determine
whether loss of NCR1 has an effect on parasite viability as a result
of the potential accumulation or mislocalization of cholesterol
within mutant parasites. Results show that the addition of excess
LDL in the medium, i.e. 10-times more than normal medium (10%
FBS), did not affect the intravacuolar development of TgNCR1-
deficient parasites(Figure 6B). A ,150%increase inreplicationrate
was observed for the DNCR1 strain compared to the parental strain
grown in excess LDL, which parallels the increased replication rate
of the DNCR1 strain in normal medium. We showed previously
that exposure of T. gondii to a medium depleted in LDL results in a
slowdown of parasite development as smaller vacuoles were
observed compared to parasites developing in complete medium
[2]. When TgNCR1-deficient parasites were incubated in the
absence of LDL, they grew slower than in medium containing 10%
FBS, but still showed a growth advantage over the parental strain
grown in LDL-free medium (Figure 6C). Thus, the DNCR1 strain
displays no significant change in sensitivity to extracellular
cholesterol compared to parental parasites. This may predict a
primary role for TgNCR1 that is unrelated to cholesterol transport.
The NPC disease is characterized by lysosomal sequestration of
endocytosed LDL-cholesterol, abnormal enrichment of unesteri-
fied cholesterol in trans-Golgi cisternae and anomalies in
intracellular sterol trafficking [9]. We then monitored the
cholesterol status in TgNCR1-deficient parasites compared to
control parasites. In a first set of experiments, parasites were
stained with filipin (Figure 7A). A fluorescence pattern was
associated with the parasite’s pellicle and apical rhoptries in both
the DNCR1 and parental strains when cultivated in 10% FBS.
When excess LDL was added to the medium, TgNCR1-deficient
parasites did not show any major sites of cholesterol accumulation
as is the case in NPC1-deficient mammalian cells. To validate our
microscopic observations, we measured the levels of free
cholesterol molecules, at monomeric and oligomeric states by
mass spectrometry (Figure 7B). Our results established that the
overall concentrations of monomeric, dimeric and trimeric
cholesterol in DNCR1 were similar to the parental strain.
TgNCR1-deficient parasites contain numerous lipid
bodies in their cytoplasm and accumulate several species
of cholesteryl esters
To examine whether the lack of NCR1 might impact the
metabolism of lipids other than cholesterol, TgNCR1-deficient
and control parasites were stained with Nile Red. This dye
fluoresces when trapped inside lipid bodies allowing the exami-
nation of the cytosolic stores of neutral lipids in cells. Data show
the presence of abundant lipid bodies in the DNCR1 strain, which
were greater in size and number than those found in the parental
strain (Figure 8A). The DNCR1 parasites could produce up to nine
lipid bodies, with an average of five lipid bodies per cell whereas
control parasites contained two lipid bodies per cell on average
(Figure 8B). We previously described that Toxoplasma can store
both esters of cholesterol [37] and triglycerides [38] in lipid bodies.
The nature of neutral lipids accumulated in TgNCR1-deficient
parasites was then investigated by mass spectrometry. Quantitative
analysis of the cholesteryl ester species present in wild-type
Toxoplasma was performed in detail (Table 1). As predicted by the
detection of acyl-CoA:cholesterol acyltransferase (ACAT) activities
in the parasite, cholesteryl esters were abundant in the parasite. Of
the 21 molecular species detected in Toxoplasma, cholesteryl oleate
C18:1 (42%) and palmitate C16:0 (26%) were the main esters as is
the case in mammalian cells but the parasite also had uniquely
large amounts of cholesteryl eicosanoate C20:1 (7%). In addition,
the parasite contained to a lesser extent, cholesterol palmitoleate
C16:1, stearate C18:0, linoleate C18:2, arachidonate C20:4 and
some polyunsaturated C22 fatty acids. The other cholesteryl ester
fatty acid species shown in Table 1 represented 3.5% of the total
species. Interestingly, TgNCR1-deficient parasites showed an
overall increase in the cholesteryl ester content, with the greatest
accumulation of cholesteryl linoleate, arachidonate, C20:3 and
some very-long-chain polyunsaturated fatty acids (Figure 9).
In parallel, we examined the triglyceride content of the parasites
(Figure 10). Toxoplasma contained pools of triglycerides with either
palmitate:oleate:stearate or palmitate:oleate:linoleate, and these
lipid species were also detected in TgNCR1-deficient parasites at
similar levels. These results suggest that lipid bodies in the DNCR1
parasites are particularly enriched in cholesterol esters, as a result
of an overproduction of these lipids and/or a dysregulation of the
cholesterol cycle.
TgNCR1-deficient parasites accumulate several species of
very-long-chain fatty acid sphingolipids
The NPC mutation has been also shown to impact the levels of
sphingolipids [21,39]. We then determined the status of sphingo-
lipids in DNCR1 parasites. A previous quantitative study reported
that sphingomyelins and ceramides represent 1.5 and 4.7% of total
polar lipids respectively, in T. gondii [40]. We used quantitative
mass spectrometry analyses to identify 10 different species of
sphingomyelins (Table 2) and 11 species of ceramides (Table 3) in
Toxoplasma controls. The main molecular species of sphingomy-
staining of the TLC plate, the band intensity of FC and GM1 (yellow asterisks) were measured by densitometry. Error bars indicate SEM, n=3
(*, P,0.05; **, P,0.01 comparing TgNCR1-hNPC1-transfected cells with vector alone).
doi:10.1371/journal.ppat.1002410.g003
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blots were probed with anti-HA antibodies, revealing a single band at ,140-kDa in transgenic parasites. No band was visible on immunoblots of wild-
type parasites (not shown). B–C. Immunodetection of HA-TgNCR1 in transgenic parasites using anti-HA antibodies for IFA (in B) or immunogold
staining (in C). HA-TgNCR1 is dominantly associated with the IMC. The image in C shows two adjacent parasites (P1 and P2, as represented in the
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C22:1 (28%) and stearic acid C18:0 (13%). Sphingomyelin species
with eicosenoic acid C20:1 and behenic acid C22:0 were detected
though in lesser abundance. Other species represented about 2%
of the total sphingomyelins, with palmitic acid corresponding to
1%. The main species of ceramides in the parasite was palmitic
acid (83%). Ceramides with stearic acid totaled 8% while the other
ceramide species represented about 10%, with oleic acid less than
1%. Overall, the profiles of sphingomyelins and ceramides in
Toxoplasma were quite different from those in mammalian cells in
which oleic acid and palmitic acid are prominently represented.
The sphingolipid profiles of TgNCR1-deficient parasites showed
significant increases in both sphingomyelin and ceramide species
containing lignoceric acid C24:0 and selacholeic acid C24:1
(Figures 11 and 12). In TgNCR1-deficient parasites, the ceramide
C22:0 and the sphingomyelin containing palmitic acid and
palmitoleic acid were also more abundant compared to the
parental strain. Finally, to provide a complete overview of the lipid
profiles in the DNCR1 strain, the status of phospholipids other
than sphingomyelins was analyzed by quantitative mass spectrom-
etry. It has been previously observed that the parasite phospholipid
class distribution is significantly different from that of mammalian
cells [40,41]. Phosphatidylcholine is the most prevalent lipid,
accounting for 61–75% of total phospholipids. The next most
abundant lipids are phosphatidylethanolamine (10–16%), phos-
phatidylinositol (3.6–7.5%) and phosphatidylserine (5.6–6%). Data
showed no difference in the levels of phosphatidylcholine and
phosphatidylinositol between the DNCR1 and parental strains
(Table S1). Only very few species of phosphatidylethanolamine
and phosphatidylserine were significantly higher (up to a 3-fold
increase) in TgNCR1-deficient parasites as compared to controls.
Altogether, these data suggest that the main role of TgNCR1 in
the parasite is in regulating the homeostasis of many different
lipids.
TgNCR1-deficient parasites shift to the endopolygeny
replication mode
We next examined the morphology of the TgNCR1-deficient
parasites at the ultrastructural level. Astonishingly, nearly all EM
sections demonstrated profiles of dividing parasites, indicating that
these knockout parasites relentlessly underwent endodyogeny
(Figure S10). While images capturing parasite endodyogeny can
also be observed in wild-type parasites, it is at a much lower
frequency. A representative PV containing many dividing
TgNCR1-deficient parasites is shown in panel A of Figure 13, in
which nascent daughter cells were visible within the cytoplasm of
each mother cell. The sequential steps in parasite endodyogeny
were then analyzed in detail (Figure S12). At the onset of daughter
cell formation, the cytoplasm of the mother cell contained one or
two thin, and either elongated (Figure S12, panel a) or horseshoe-
shaped structures (Figure S12, panel b) that had the same electron-
density as the IMC beneath the mother plasma membrane (Figure
S12, panel a). These tubules likely represent the initial pieces of the
newIMCthatwillassembletoprovidethe cytoskeletalscaffoldingof
developing daughter cells. As endodyogeny progresses, the nascent
IMC extended in size and enveloped the dividing organelles, e.g.,
nucleus (Figure S12, panel c), Golgi and apicoplast (Figure S12,
panel d), and the organelles produced de novo, e.g., rhoptries
(Figure S12, panel Bd-e) and micronemes (Figure S12, panel e). The
plasmalemma theninvaginatedaround the daughters. Concomitant
to the emergence of daughter parasites with an intact pellicle, the
mother mitochondrial network moved to the posterior end of
nascent parasites, bifurcated and entered the daughter scaffolds
(Figure S12, panels f and g). These EM observations did not reveal
any obvious defects in organellar partioning in daughters lacking
NCR1, based on studies tracking fluorescent organelles in wild-type
parasites by time-lapse microscopy. This suggests that the process of
division of the DNCR1strainoccurs in a similar fashionas found for
wild-type parasites.
The frequency of multiple daughter formation is usually rare in
wild-type parasites and is typically in the range of 0.5 to 3% [42,43].
Interestingly, we observed a significant high number of cases in
which more than two daughters wereformed withina single mother,
as illustrated by immunofluorescence microscopy using the protein
marker IMC1 to observe the IMC of nascent daughters within the
mother cells (Figure 13B). We could observe the different steps of the
construction of the multiple daughters per mother cell (Figure 13C).
The budding seemed synchronized, and the time for multiple
daughter formation did not reveal and delay compared to parasites
undergoing normal binary division in the same vacuole. Transmis-
sion EM analysis also confirmed the presence of several individu-
alized nuclei encircled by the IMC as a sign of assembly of new
parasites (Figure 13D). To quantifythisgrowthdefect, we stained the
DNCR1 and parental strain with DAPI and IMC1 and counted the
PV containing parasites producing more than 2 daughters per
mother (Figure 13E). Data show a dramatic increase in the number
of endopolygeny events in the mutants with some mother parasites
assembling as many as five daughters at the same time.
TgNCR1-deficient parasites have an unusual cell cycle
with a long S phase and short G1 phase
Toxoplasma tachyzoite replication differs from the classic animal
cellcycleastheydivideusingathree-phasecycle(G2maybeshortor
missing) with the G1 interphase period comprising 40–60% of the
parasite’s doubling time [reviewed in 35]. S phase distributions in T.
gondiiare also peculiar, with late S phase parasites (1.8N) being more
numerous than early S phase parasites. Internal daughter budding
appears to initiate in late S phase. We performed flow cytometry
analysis on the DNCR1 strain to examine the cell cycle profiles of
these mutants, in comparison with control parasites and VERO cells
fromwhich these parasiteshavebeen isolated (Figure 14). Data show
that the percentages of parasites in G2/M phase were comparable
between the mutant and parental strains and represented consis-
tently a fraction between ,10–12% of the total population.
However, the average percentage of TgNCR1-deficient-parasites
in S phase was significantly higher than for control parasites (about
61% vs. 41%). Consequently, the population of parasite mutants
during the G1 phase corresponded to ,24% only.
demarcated area of the inset showing transgenic parasites stained by IFA) in a PV to emphasize the continuous staining of HA-TgNCR1 along the IMC.
PM, plasma membrane. Bar is 150 nm. D–E. Immunodetection of HA-TgNCR1 in transgenic parasites using anti-HA antibodies for IFA (in D) or
immunogold staining (E). HA-TgNCR1 is also located to the IMC of nascent daughter cells (d cell) as shown by arrows. m cell, mother cell. Bar is
150 nm. F. ImmunoEM on the transgenic parasites showing vesicular staining in addition to the IMC. Several vesicles close to the IMC were also
decorated with gold particles (arrowheads in panels a and b). PM, plasma membrane. Bars are 150 nm. G. Stereological analysis of immunogold
labeling demonstrating the preferential localization of HA-TgNCR1 on the IMC and neighboring vesicles in intracellular T. gondii. Density (gold
particles per mm2) of labeled structures was determined from 30 cryosections. Percentage of individual intracellular compartment density was
determined from the sum of gold density normalized for the variation in expression of TgNCR1. NE, nuclear envelope.
doi:10.1371/journal.ppat.1002410.g004
Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 10 December 2011 | Volume 7 | Issue 12 | e1002410The phenotype of TgNCR1-deficient parasites is
associated with long PV membranous extensions
We next wanted to focus our attention to the PV of the DNCR1
strain to detect any peculiar morphological changes compared to
the parental strain. A feature commonly shared by many
intravacuolar pathogens is the formation of membranous tubules
or fibers that extend away from their vacuole to facilitate their
replication [44–46]. These filamentous structures contain many
pathogen-derived proteins. Toxoplasma also forms long tubules
extending from the PV membrane containing proteins released
from dense granules, e.g., GRA7, GRA10, GRA14 proteins [3,45]
(Figure S13). We then examined the morphology of the PV
Figure 5. Validation of the targeted deletion of NCR1from the Toxoplasma genome. A. Top: schematic showing the three primer sets used
to evaluate the parental strain DKu80 and DNCR1 for replacement of NCR1 with the selectable marker HXGPRT; the presence or absence of NCR1 and
HXGPRT is shown on the gel (bottom). B. Southern blot of DKu80 and DNCR1 strains. Genomic DNA was isolated from each strain, digested with AgeI
to excise a 2.2-kb fragment, run on an agarose gel, transferred to a nylon membrane and hybridized with a 0.9-kb probe that is part of the HXGPRT
cassette.
doi:10.1371/journal.ppat.1002410.g005
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this membrane by fluorescence microscopy.
Fibroblasts were infected with the DNCR1 or parental strain for
36 h for double IFA to detect GRA3 and GRA7 on the PV
membrane (Figure 15A). Both strains form long extensions
originating from the PV. In multi-infected cells, some of these
tubules were connecting two PV. The fluorescent signal for GRA3
and GRA7 appeared much brighter and homogenous for the
extensions of the PV containing TgNCR1-deficient parasites than
those generated by the parental strain, suggestive of more robust
extensions. Morphometric quantification of the diameter and length
ofPVmembranousextensions confirmed that theyweresignificantly
thicker and longer for TgNCR1-deficient Toxoplasma (Figure 15B).
Interestingly, we observed that several PV of TgNCR1-deficient
parasites, although located to different host cells, were connected
together by these PV membranous extensions (Figure 16A). In
some occasions, two PV of the parental strain residing in adjacent
cells were also seen joined together by PV tubules, suggesting that
this phenotype plays a physiological role during parasite
development. Close observations of the PV of TgNCR1-deficient
parasites revealed that the closer two PV were to each other, the
thicker the connecting tubules were (Figure 16B, panels a to c). A
plausible scenario would be that the tubular structures bridging
two PV may be generated consequently to the split of a PV into
two vacuoles that stay connected by their PV membrane which
elongates as the two PV separate from each other. Finally, we
observed that these membranous connections between PV were
maintained after host cell division, and dramatically increased in
length as the two PV move apart (Figure 16B, panels d to e). The
tubules originated from the PV membrane are likely made of
lipids. The abundant and thick membranous extensions formed by
TgNCR1-deficient parasites may suggest that these mutants may
have an unusual membrane lipid biogenesis.
Disruption of NCR1 results in increase in virulence in mice
It still remains unclear why TgNCR1-deficient parasites can
generate more than two daughters from one mother cell.
Nevertheless, if mutant daughter cells are viable and infective,
the increase in their production may contribute to the more rapid
expansion of the knockout population in vivo.The fast develop-
ment of TgNCR1-deficient parasites in vitro prompted us to
examine whether the DNCR1 strain is particularly virulent in
mice. To examine the role of TgNCR1 in Toxoplasma infectivity,
mice were infected with either the DNCR1 or parental strain after
intraperitoneal injection, and mice survival was monitored daily.
All mice infected with the parental strain died by day 10
(Figure 17). By comparison, mice parasitized with TgNCR1-
deficient T. gondii showed higher susceptibility to infection as all
mice systematically died one day earlier, as monitored in three
independent trials. This suggests that TgNCR1-deficient parasites
are slightly more virulent than control parasites.
Discussion
As a starting point for studies on lipid transport and regulatory
processes within the parasite, the aim of this work was to
investigate the role of a unique SSD-containing protein, TgNCR1,
expressed by T. gondii. The sequence of TgNCR1 predicts an
uncharacterized Niemann-Pick, type C1-related protein with
significant identity (37%) to human NPC1. The TgNCR1
sequence predicts a 1178-residue protein (131-kDa) with four
potential N-glycosylation sites, and regions homologous to the
Patched Homology Domain (PHD), the SSD and the sterol-
binding domain (SBD) [5]. Hydropathy plots and topology
predictions of TgNCR1 and human NPC1 suggest a striking
conservation of the secondary structure between the two proteins,
in that both have 11 to 12 transmembrane domains whose spacing
is conserved. Interestingly, a NPC1 homolog is present in several
species of apicomplexan parasites and their predicted sequences
are closely related to that of TgNCR1. Mutations in human NPC1
that cause NPC disease lay in residues conserved in TgNCR1.
When expressed in mammalian cells with impaired NPC1 activity,
TgNCR1 can restore the sterol and GM1 trafficking. Overall,
despite the evolutionary distance of mammals and protozoa,
Figure 6. Growth features of TgNCR1-deficient parasites in vitro. Quantification of the replication rate of the DNCR1 and parental strains in
medium with variable amounts of cholesterol. [
3H]uracil incorporation was measured using HFF infected with the DNCR1 or parental strain for the
indicated times in (A) medium containing 10% FBS (nominal LDL concentration: 0.1 mg/ml: normal serum), (B) medium containing 10% FBS
containing 1 mg/ml LDL (LDL: rich serum) or (C) medium containing 10% FBS depleted of LDL (LDL-free serum). Values of uracil incorporation are
means 6 SEM from three separate experiments. Differences between values obtained for the two strains were statistically significant (P,0.05).
doi:10.1371/journal.ppat.1002410.g006
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at least for LDL-cholesterol and sphingolipid movement.
The ability of TgNCR1 to complement a mutant human NPC1
is a priori intriguing given that the core problem of the NPC disease
is an accumulation of cholesterol and other lipids in certain
endocytic organelles [9,47]. T. gondii does not have a process of
receptor-mediated uptake of sterols nor contains degradative
lysosomes. In fact, though T. gondii is auxotrophic for cholesterol
derived from plasma LDL [2], the parasite internalizes this lipid by
using membrane translocators [5]. Nevertheless, the detection of
cholesterol transport activity in NPC1-deficient cells expressing
TgNCR1 implies that the parasite protein can bind cholesterol,
perhaps by its putative SBD, and is maybe recognized by
necessary accessory proteins in mammalian cells, e.g., NPC2 for
cholesterol egress from endo-lysosomes. Though NPC2 proteins
are highly conserved across genera that have clear NPC1
orthologs, a gene encoding a NPC2-like protein could not be
identified in T. gondii. All of these intriguing observations predict
that TgNCR1 would function in an unconventional way in
Toxoplasma, likely distinct from a role in exogenous cholesterol
transport. To explore the function of TgNCR1 in Toxoplasma,a
parasite strain lacking the NCR1 gene was generated. DNCR1
Figure 7. Cholesterol detection and quantification in TgNCR1-deficient parasites. A. Fluorescence microscopy using filipin to visualize the
presence of cholesterol in the membrane of the DNCR1 and parental strains 24 h p.i. in either 10% FBS or 10% LDL-deficient serum (LPDS) containing
1 mg/ml LDL. No major difference in filipin staining is detectable. Arrowheads pinpoint parasite rhoptries revealed by filipin. B. Quantitative analysis
of MRM spectra from the DNCR1 and parental strains showing relative levels of cholesterol monomers (mono), dimers (di) and trimers (tri). No
significant differences could be observed between the two strains. Data are means 6 SD from 3 independent populations of control and mutant
parasites.
doi:10.1371/journal.ppat.1002410.g007
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replication. Altering the environmental cholesterol conditions by
either starving Toxoplasma-infected cells for LDL or feeding
infected cells with excess LDL, did not disturb the growth of
knockout parasites differently than the parental population. The
DNCR1 strain is not overloaded with free cholesterol, as are
mutant mammalian NPC1 cells but instead abnormally accumu-
lates sphingolipids and cholesteryl esters, and to a lesser extent,
phosphatidylethanolamine and phosphatidylserine. Since NPC1
proteins universally function as lipid transporters, the observed
accumulation of lipids in the DNPC1 strain is most likely the
primary effect resulting from the loss of NCR1. Consequently,
TgNCR1 seems to be involved in controlling the intracellular
levels of specific lipids in the parasite. The yeast NPC homolog
(NCR1), which is localized to the vacuole, functions in
sphingolipid recycling and not in sterol transport even though
yeast NCR1 complements the loss of NPC1 in mammalian cells
[21]. NPC1 proteins also bear intriguing similarities to the
Resistance-Nodulation Division (RND) system of bacterial per-
meases, which transport acriflavine and fatty acids [48].
Heterologous expression of RND from Escherichia coli in human
NPC1-deficient fibroblasts results in the accumulation of acrifla-
vine and fatty acids, but not the restoration of the NPC1 sterol
accumulation phenotype. As Toxoplasma, yeast and bacteria do not
internalize sterols from their external environment by endocytosis,
our study here widen the concept proposed by SL Sturley [16] that
in cells that do not ingest exogenous cholesterol in endocytic
organelles, the NPC1 proteins do not primarily function as a
cholesterol sensor/transporter, but as a regulator of the movement
of other lipophilic substrates including sphingolipids. In this case,
the role of NPC1 in higher eukaryotic cells as a cholesterol
transporter might have arisen during evolution concomitantly to
the development of receptor-mediated pathways for sterol uptake.
Nevertheless, it remains possible that the accumulation of
cholesterol in mammalian late endosomes may not be the primary
cause of NPC disease but a secondary effect as a consequence of
impaired transport of other metabolites aside from sterols.
The abnormal lipid accumulation resulting from the loss of
NCR1 in T. gondii leads to secondary defects including the
stimulation of daughter formation, virulence, membrane biosyn-
thesis and lipid body biogenesis. Mutants produce more progeny
parasites than controls. The accumulation of mutant parasites in S
Figure 8. Production of lipid bodies by TgNCR1-deficient parasites. A. Fluorescence microscopy using Nile Red to stain lipid bodies in the
DNCR1 and parental strains showing abundant fluorescent structures in TgNCR1-deficient parasites. B. Quantitative distribution of lipid bodies in the
two parasite strains. Nile Red positive structures were counted, revealing greater number of lipid bodies in the DNCR1 strain. Insets show TgNCR1-
deficient parasites with 4 to 9 large lipid bodies.
doi:10.1371/journal.ppat.1002410.g008
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phenomenon has not been observed in the parental strain or wild-
type population of T. gondii. This feature may be linked to the
propensity of TgNCR1-deficient parasites to form multibuds with
multiple nuclear divisions between rounds of S and G2/M phase.
During endopolygeny, the parasites reinitiate DNA synthesis
bypassing G1 checkpoints but then re-coordinate the cell cycle as
they reach the next mitosis. By analogy, mammalian tumor cells
with high proliferation rate, e.g., HeLa cells are also characterized
by cell cycle alterations with the observed accumulation of cells in
S phase and reduction of cells in G1 phase. Such a deregulated cell
cycle in cancer cells is mainly due to defective genome-integrity
checkpoints, leading to abnormal DNA content. Several cell cycle
checkpoints with controllers of cyclin-Cdk activity (G1, START
(G1/S) checkpoints and mitotic controls) have been characterized
in Toxoplasma [35]. However, the synchronization of multibud
formation in the DNCR1 strain precludes the idea that these
parasites escape from the regulatory systems of checkpoints, which
complete mitosis in synchrony and control the quality of progeny.
TgNCR1 localizes to the IMC, a unique cortical system of
membrane cisternae connected to the plasma membrane. As in
mammalian cells, most of the parasite’s cholesterol is concentrated
at the plasma membrane [49]. However, it has also been
documented that the IMC contains cholesterol-rich domains in
which the parasite myosin motor machinery is immobilized [50].
These domains are critical for parasite gliding motility and
attachment to a substrate. The location of TgNCR1 to the parasite
IMC underlines the possibility that TgNCR1 may act as a catalyst
to assemble cholesterol-rich. The highly dynamic properties of the
IMC during parasite replication could facilitate the trafficking and
mobilization of lipids necessary for daughter cell formation.
Disruption of NCR1 results in endopolygeny. This suggests that the
function of TgNCR1 may be relevant in some way for
coordinating normal progeny number and assembly, for example
by delivering appropriate amount of lipids for membrane/
organelle biosynthesis. It has been reported that genetic factors
or local conditions increase the tendency to form multiple
daughters [42]. For example, the ISP1 protein, which is located
to the apical portion of the IMC, is involved in the targeting of
many proteins to the IMC and seems to play a role in
synchronizing endodyogeny [51]. Interestingly, T. gondii lacking
ISP1 also assemble more than two siblings per mother cell.
Observations based on TgNCR1 and ISP1 mutants suggest an
important contribution of the IMC to the regulation of parasite
division pathways, and thus to the control of infectivity.
Deletion of TgNCR1 from parasites leads to an increase in
virulence as mice infected by the mutant strain succumb slightly
faster than mice infected with control parasites. The fitness of
TgNCR1-deficient parasites in vivo may be due to their higher
propensity to produce multiple daughters, and therefore to
disseminate faster within the host. Alternatively, the high content
of sphingolipids inTgNCR1-deficient parasites may lead to
increased virulence for several reasons: i) these lipids may play
an important role to promote the parasite’s intracellular
development, e.g., by the induction of long PV membranous
extensions that facilitate the parasite colonization of host cells; ii)
the sphingolipids may act as immunomodulators during the
progression of the infection; and iii) these lipids may stimulate the
expression of virulence factors. First, the excess sphingolipids may
promote intracellular parasite development as in mammalian cells
it is known that sphingolipids are implicated in the regulation of
cell growth and differentiation via DNA stimulation [52]. These
lipids act as intracellular second messengers, and when added
exogenously, they elicit diverse cellular responses related to cell
division. Second, in different mammalian cell types, sphingolipids
and their derivatives are involved in inflammation and can initiate
parts of the inflammatory process by activating pro-inflammatory
transcription factors [53]. It is known that the overproduction of
pro-inflammatory cytokines, particularly IL-12, INF-c, and TNF-
a by mice infected with virulent strains of T. gondii contributes to
the animal death due to apoptosis in vital organs [54]. Lastly, the
mutant parasites may use its sphingolipids as part of its signaling
machinery to stimulate the expression of virulence factors secreted
into the host cell, e.g. ROP proteins that control the host
transcriptional responses by subverting STAT3 and STAT6
signaling [55].
Though there are widespread disruptions in lipid metabolism in
TgNCR1-deficient parasites, the observed increase in lipid body
biogenesis may represent a bypass pathway utilized by the parasite
to repress the consequences of the loss of NCR1. Bypass pathways
have been described in mammalian cells expressing a mutated
NPC1 protein. For instance, chemicals that activate protein kinase
C or elevate cytosolic calcium can revert the NPC phenotype [47].
In addition, overexpression of Rab7 (involved in early/late
endosome to lysosome transport) or Rab9 (involved in late
endosome to Golgi transport) results in a reduction in the amount
of cholesterol stored in late endosomes. Overexpression of Rab7 or
Rab9 also induces an increase in Nile Red staining, which
presumably reflects an increased storage of neutral lipids,
including cholesterol esters in lipid bodies. The synthesis of
cholesteryl esters, which have lower biological toxicity than free
Table 1. Cholesteryl ester content and relative abundance in
Toxoplasma.
SPECIES % CHOLESTERYL ESTER SPECIES
C18:1 42.4
C16:0 25.5
C20:1 7.2
C16:1 5.5
C18:0 3.4
C18:2 3.0
C20:4 2.6
C22:6 1.9
C22:5 1.8
C22:4 1.7
C20:3 1.5
C16:2 0.6
C24:1 0.6
C22:1 0.5
C20:2 0.4
C18:3 0.3
C22:0 0.3
C22:3 0.3
C24:4 0.2
C20:5 0.2
C24:3 0.1
Quantitative analysis of MRM spectra from T. gondii showing the percent of
species of cholesteryl esters.
Data have been collected from 3 different parasite preparations. Total area
intensity is 2,651,000 cps (100%).
doi:10.1371/journal.ppat.1002410.t001
Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 15 December 2011 | Volume 7 | Issue 12 | e1002410Figure 9. Content of cholesteryl esters in TgNCR1-deficient parasites. The levels of various species of cholesteryl esters were quantified from
MRM spectra of the DNCR1 and parental strains. Statistically significant differences in the amounts of several cholesteryl esters were found in
TgNCR1-deficient parasites. The y axes are in cps. Data are means 6 SD from 3 independent populations from each strain.
doi:10.1371/journal.ppat.1002410.g009
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cholesterol, and this process can then compensate for the loss of
NPC1 activity. By analogy, the accumulation of additional lipid
bodies and the bulky production of cholesteryl esters in TgNCR1-
deficient parasites may be viewed as a compensatory mechanism
activated by the mutant parasites to circumvent the lipotoxic
effects of free cholesterol accumulation. Although we do not know
whether there is transient accumulation of free cholesterol in
mutant parasites, the high number of cholesteryl ester-containing
lipid bodies would implicate TgNCR1 in cholesterol movement
e.g., delivery of cholesterol to organelles. In fact, the trafficking of
cholesterol to large-size lipid bodies has been observed in human
NPC fibroblasts [56]. The enlargement of lipid bodies is caused by
the abnormal fusion of lipid bodies with one another, but upon
correction of the NPC phenotype by ectopic expression of NPC1,
cholesterol is targeted to small-sized lipid bodies. It has been
proposed that the activity of NPC1 resides in the maintenance of
normal sized lipid bodies, possibly by preventing their fusion. T.
gondii contains two ACAT enzymes located to the ER, which are
both essential for parasite development [37; Lige and Coppens,
data in preparation]. Inventories of cholesteryl esters produced by
Toxoplasma reveal a predominant content of cholesteryl oleate and
palmitate (,70%) as well as other esters with polyunsaturated fatty
acids that are rarely found in mammalian cells. An overall increase
of ,30% in cholesteryl esters is observed in TgNCR1-deficient
Toxoplasma, reflecting that the cycle of esterification/hydrolysis of
cholesterol esters is severely dysregulated in mutant parasites. This
phenotype may result in an impairment of cholesteryl ester
hydrolysis to free cholesterol. The Toxoplasma genome contains a
gene coding for a cholesteryl ester hydrolase homolog
(TgME49_038200) that can be involved in this function.
Alternatively, ACAT activities can be stimulated in mutant
parasites in response to accumulated free cholesterol. Concomitant
to the increase in cholesteryl ester content, the number and size of
lipid bodies are dramatically enhanced in mutant parasites,
probably to collect excess cholesteryl esters. While TgNCR1 has
never been detected on parasite lipid bodies, the accumulation of
lipid bodies and cholesteryl esters in the DNCR1 strain suggest
that TgNCR1 may regulate the cycles of cholesterol esterification
and lipid body content.
Lipidomic analyses reveal that Toxoplasma contains more than
twenty different species of sphingolipids consisting of both saturated
and unsaturated fatty acids. The origin of sphingolipids in the
Figure 10. Content of triglycerides in TgNCR1-deficient parasites. Triglyceride levels were quantified from MRM spectra of the DNCR1 and
the parental strains. Levels of two species of triglycerides: POS (palmitate:oleate:stearate) and POL (palmitate:oleate:linoleate) were similar in the two
parasite populations. The y axes are in cps. Data are means 6 SD from 3 independent populations from each strain.
doi:10.1371/journal.ppat.1002410.g010
Table 2. Sphingomyelin content and relative abundance in
Toxoplasma.
SPECIES % SPHINGOMYELIN SPECIES
C20:0 44.0
C22:1 28.0
C18:0 12.6
C20:1 7.8
C22:0 5.5
C16:0 1.0
C24:1 0.4
C18:1 0.4
C16:1 0.2
C24:0 0.1
Quantitative analysis of MRM spectra from T. gondii showing the percent of
species of sphingomyelins.
Data have been collected from 3 different parasite preparations. Total area
intensity is 158,990,000 cps (100%).
doi:10.1371/journal.ppat.1002410.t002
Table 3. Ceramide content and relative abundance in
Toxoplasma.
SPECIES % CERAMIDE SPECIES
d16:0 82.9
d18:0 8.0
d24:1 3.3
d24:0 2.2
d16:1 0.9
d20:0 0.8
d18:1 0.7
d20:0 0.6
d26:0 0.3
d26:1 0.2
d22:1 0.1
Quantitative analysis of MRM spectra from T. gondii showing the percent of
species of ceramides.
Data have been collected from 3 different parasite preparations. Total area
intensity is 1,808,300 cps (100%).
doi:10.1371/journal.ppat.1002410.t003
Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 17 December 2011 | Volume 7 | Issue 12 | e1002410Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 18 December 2011 | Volume 7 | Issue 12 | e1002410parasite remains unclear. Evidence for de novo sphingolipid
synthesis by Toxoplasma is based on the indirect effect of drugs
known to block sphingolipid biosynthesis in mammalian cells or
fungi but their enzymatic targets have not been identified in the
parasite [57]. Other studies support the active scavenging of host
cell-derived ceramides by Toxoplasma [58; Romano and Coppens,
data in preparation]. Like in NPC1-deficient mammalian cells, the
homeostasis of sphingolipids is altered in TgNCR1-deficientpar-
asites, with a selective accumulation of several species of very-long-
chain fatty acids. A few species of phosphatidylethanolamine and
phosphatidylserine also show increased levels in the mutant
parasites. The cause of this accumulation is unknown. One possible
explanation may be linked to the multiple biosynthetic pathways of
serine. Besides being the precursor of ceramides, serine is involved
in the formation of phosphatidylserine and phosphatidylethanol-
amine through ethanolamine synthesis. Increases in the levels of
phosphatidylethanolamine and phosphatidylserine may be due to
the enhanced synthesis of these phospholipids via the diversion of
serine from sphingolipid pathways. The dysregulation of the
sphingolipid levels in the DNCR1 strain may have an indirect
effect on the metabolism of phospholipids, which use the same
precursor. Interestingly, an accumulation of other phospholipids,
e.g., phosphatidylcholine has been reported in NPC1-deficient
hepatocytes though the mechanism has not been explored [59].
In mammalian cells, sphingolipid metabolism is closely coordi-
nated with that of sterols as these two lipids associate physically and
there is considerable cross-talk between their metabolic pathways
[60]. Among the cooperative activities of cholesterol and sphingo-
lipids is the nucleationof lipid microdomains. Imbalancein either of
these lipids results in disease pathology. It is possible that
perturbations in sphingolipid levels in the DNCR1 mutant parasites
may be related to changes in cholesterol homeostasis, either as feed-
forward or feed-backward sequelae of cholesterol imbalance. In
addition, the accumulation of sphingolipids in the DNCR1 strain
may be due to impaired catabolism, altered vesicular transport of
these lipids and/or of cholesterol, or blockade of sphingolipid
export. In eukaryotic cells, sphingolipids and their metabolites play
keyrolesbothasstructuralcomponents ofmembranes and signaling
molecules that mediate responses to physiologic cues and stresses
[61]. Sphingolipids are particularly abundant on the extracellular
face of the plasma membrane, where they participate in cell-cell
communication and host-pathogen interactions [62,63]. The
structural features of sphingolipids can influence the order of the
lipid phase, and impact membrane curvature and thickness [64,65].
The distribution, function and regulation of sphingolipids in
Toxoplasma as well as the contributions of these lipids to parasite
development are unknown. Long extensions derived from the PV
membrane are observed in mutant parasites. It is then tempting to
propose that these extensions may result from the selective
incorporation of sphingolipids, i.e. sphingomyelins in this mem-
brane, which contributes to the stability of the extensions. It might
be of interest to compare the Toxoplasma PV tubules extending into
the host cytoplasm with the tubovesicular network derived from the
PV of intraerythrocytic Plasmodium that also pervades the host
cytosol. Interestingly, the biosynthesis of sphingolipids in the
malaria parasite is an import feature of this tubovesicular network
and its membranes accumulate specific sphingolipids including
sphingomyelin [66,67]. The physiological role of such extensions in
Toxoplasma is still unknown. They may participate in host cell
remodeling by deploying parasite proteins into the host cell and
recruiting host organelles to the PV. These extensions may also
serve as a route for exchange of material between two PV. The
intracellular bacterium Chlamydia trachomatis forms long fibers
extending from the inclusion membrane into the host cytosol
[37], and it has been proposed that the fibers play a role in
facilitating the generation of new infective vacuoles, and therefore
promoting bacteria replication in the host cell. Some PV
membranous extensions can also connect two PV located in
differenthostcellsandourpreliminarystudiesrevealthepresenceof
these extensions inside nanotubules connecting two mammalian
cells (Romano and Coppens, data in preparation). This feature may
represent an efficient means for Toxoplasma to disseminate among
cells and tissues like C. trachomatis. Nonetheless, the high abundance
of PV membranous extensions in virulent TgNCR1-deficient
parasites leads to the assumption that they could contribute to the
pathogenicity.
In conclusion, the phenotype of NPC1 deficiency in Toxoplasma
mimics in part the defects that have been observed in mammalian
cells and yeast lacking functional NPC1 proteins, regarding the
storage of multiple sphingolipid species. The accumulation of
cholesteryl estersin parasite mutants, asobserved in hepatocytesbut
not in other mammalian cells [59], is rather intriguing but may
reflect the unusual properties of cholesterol metabolism in the
parasite. Our results suggest that TgNCR1 may be an important
contributor to lipid homeostasis in T. gondii. How precisely this
protein exerts its action, e.g. as a detector of lipid levels in
membranes, lipid translocator or negative regulator of lipid
production, remains to be elucidated. One challenge for the future
is to clarify the source of sphingolipids for the parasite, and the
regulationandcoordinationofsphingolipidproductionwith regards
to parasite growth and virulence. Lipid moleculesplay an integrated
role in human disease, and when one of them is misregulated,
pathology frequently ensues. The control of levels of many lipids is
obviously lost in the DNCR1 strain, and yet these parasites can
overcome these lipidic perturbations and remain infective. On the
one hand, these parasites adeptly respond to NCR1 loss by
producing lipid bodies for the storage of excess lipids. On the other
hand, TgNCR1-deficient Toxoplasma seems proficient in using lipids
to build new membranes for organelle biogenesis. The DNCR1
strain provides an attractive model for studying cell division in
Apicomplexa. In pursuit of a deeper understanding of the
coordinationofthisprocess,ourmutantparasitesallowobservations
of the dynamics of the IMC and collection of ultrastructural details
about organelle partitioning between descendants.
Materials and Methods
Ethics statement
All animal procedures were approved by the Institutional
Animal Care and Use Committee of the Johns Hopkins University
following the National Institutes of Health guidelines for animal
housing and care.
Chemicals and antibodies
All chemicals were obtained from Sigma (St Louis, MO) or
Fisher (Waltham, MA) unless indicated otherwise. Solvents and
standards for chromatography were of the highest analytical
grade. Silica gel 60 thin-layer chromatography (TLC) plates
Figure 11. Content in sphingomyelins in TgNCR1-deficient parasites. The levels of several sphingomyelin species were determined by the
quantitative analysis of MRM spectra from the DNCR1 and parental strains. Higher levels of C16 and C24 sphingomyelins were measured in TgNCR1-
deficient parasites. Data are means 6 SD from 3 independent populations from each strain.
doi:10.1371/journal.ppat.1002410.g011
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PLoS Pathogens | www.plospathogens.org 19 December 2011 | Volume 7 | Issue 12 | e1002410Figure 12. Content in ceramides in TgNCR1-deficient parasites. Levels of ceramide species were determined by the quantitative analysis if
MRM spectra from the DNCR1 and parental strains. Higher levels of several very-long chain fatty acids ceramides in TgNCR1-deficient parasites were
observed. The y axes are in cps. Data are means 6 SD from 3 independent populations from each strain.
doi:10.1371/journal.ppat.1002410.g012
Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 20 December 2011 | Volume 7 | Issue 12 | e1002410(Merck KgAG, Darmstadt, Germany) were purchased through
EM Science (Gibbstown, NJ). Radiolabeled reagent [5,6-
3H]
uracil (40 Ci/mmol) was purchased from Amersham Corp.
(Arlington Heights, IL, USA). LysoTracker Red DND-99 was
obtained from Invitrogen (Carlbad, CA). Ganglioside, sphingo-
myelin and ceramide standards were purchased from Avanti Polar
Lipids (Alabaster, AL). Primary antibodies used in this study were:
commercial mouse antibodies against HA (Roche Applied
Figure 13. Peculiarities of replication of TgNCR1-deficient parasites. A. Transmission EM of TgNCR1-deficient parasites infecting HFF for
24 h. A. The PV contains many daughter parasites in formation (arrowheads). Replicating parasites were frequently observed for the DNCR1 strain. Bar
is 1 mm. B–C. IFA on DNCR1 parasites infecting HFF for 24 h stained with antibodies against IMC1 as a marker for daughter buds (arrowheads in B).
Parasites lacking NCR1 also assemble .2 daughters per round of division (arrows in B). C illustrates a parasite assembling four daughters. The process
progresses from stage 1 (appearance of cone-shaped cisterns within the cytoplasm) to stage 7 (emergence of fully-formed daughters). Intermediate
stages show that the mother cell has divided its nucleus and is budding new daughters around each separate nucleus (stained with DAPI). D.
Transmission EM of a mutant parasite as described in panel A showing the formation of four daughters (arrowheads) within the mother cell. Each
nascent daughter is delineated by its IMC. n, nucleus. Bar is 1 mm. E. Quantification of the .2 daughter phenotype in the DNCR1 and parental strains.
Parasites undergoing endopolygeny were counted based on their DAPI-stained nuclei number and scored for the percentage of vacuoles in which
parasites were assembling .2 daughters. Most PV contained parasites assembling 3 or 4 daughters in the DNCR1 strain. Values represent means 6
S.D., n=4 (*, P,0.0005).
doi:10.1371/journal.ppat.1002410.g013
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Boston, MA), EEA1 (Abcam, Cambridge, MA) and LAMP1 (BD
Biosciences, Palo Alto, CA), commercial rabbit antibody against
myc (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit
polyclonal antibody against TgGRA7 [3] and mouse monoclonal
antibody against TgGRA3 generously provided by J.F. Dubremetz
(University of Montpellier).
Mammalian cell lines, culture conditions and parasite
propagation
Mammalian cell lines used included primary human foreskin
fibroblasts (HFF), Chinese hamster ovary cells (CHO cells) and the
somatic 2-2 mutant CHO cells with defective NPC1 kindly
provided by L. Liscum (Tufts University) [29]. All of these cells
were grown as monolayers and cultivated in a-minimum essential
medium (MEM) supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine and penicillin/streptomycin (100 units/ml
per 100 mg/ml) as described [2]. The tachyzoite RH strain of
Toxoplasma gondii and modified strains were propagated in vitro by
serial passage in HFF [68]. To evaluate parasite viability, the
measurement of [
3H]uracil incorporated into the parasites was
determined as described [69].
Sequence analysis
Nucleotide and amino acid sequences were searched in the T.
gondii database (www.toxodb.org) and the NCBI database using the
BLAST algorithm [70]. Multiple sequence alignments were
created using ClustalW, and the resulting similarities were then
visualized by subjecting the alignment to BioEdit. Percent identity
and similarity were calculated using standard tool for sequence
analysis from NCBI (ncbi.nlm.nih.gov).
Cloning of full-length cDNA encoding TgNCR1
Based on the blast search results of the ToxoDB, the ORF of the
Toxoplasma homolog for NPC1 (TgNCR1: TGME49_090870) was
amplified from a T. gondii sporozoite cDNA library generously
provided by M.W. White (Montana State University) by using the
primers F-TgNCR1-P1 and R-TgNCR1-P2 (see Table S2 for the
Figure 14. Cell cycle analysis of the DNCR1 and parental strains. Flow cytometry-based DNA content measurements of the DNPC1 strain in
comparison with the parental strain and uninfected VERO cells as controls was performed at 15 h p.i. Isolated parasites from both strains and
uninfected cells were fixed in ethanol and stained with the DNA-intercalating fluorescent dye propidium iodide (PI). The histograms show
characteristic DNA distribution patterns in the three major phases of the cell cycle for each condition. The bar graph demonstrates the percentages of
cells in each phase of the cell cycle. Data are means 6 SD of three independent assays. The percentage of TgNCR1-deficient parasites accumulated in
the S phase was significantly higher than that calculated for control parasites (*, P,0.005).
doi:10.1371/journal.ppat.1002410.g014
Role of NCR1 for Lipid Regulation in Toxoplasma
PLoS Pathogens | www.plospathogens.org 22 December 2011 | Volume 7 | Issue 12 | e1002410sequences of primers used in this study). Amplified fragments
(,3.5-kb) were subcloned into pCR2.1 using the TOPO-TA
cloning protocol (Invitrogen) and the insertion was confirmed by
enzymatic digestion with EcoRI and sequencing. The cDNA
sequence of TgNCR1 has been deposited in GenBank under the
accession number JF836804.
Plasmid constructs for expression in mammalian cells
Three plasmids were engineered for functional and localization
studies of TgNCR1. The pcDNA3.1 vector allowing the
expression of proteins with a myc tag at the C-terminus driven
by a CMV promoter was used as a backbone. For the construction
of the plasmid pTgNCR1-myc, the 59 and 39 ends of the TgNCR1
sequence were PCR-modified using primers TgNCR1-P1 and
TgNCR1-P2. The resulting PCR fragment was digested with
EcoRI and HindIII before ligation into the same restriction sites in
the pcDNA3.1 vector. This construct allows the expression of
TgNCR1 in mammalian cells with a C-terminal myc tag. We also
expressed a hybrid construct in which the C-terminal 78 residues
of TgNCR1 were replaced with amino acids 1214 to1278 of
Figure 15. Characteristics of PV membranous extensions formed by the DNCR1 and parental strains. A. Double IFA on HFF infected with
either the DNCR1 or parental strain 24 h p.i. using anti-GRA3 and anti-GRA7 antibodies revealing more intense fluorescence on extensions from the
PV membrane of the TgNCR1-deficient parasites (insets). B. Quantitative analysis of PV membranous extensions for both strains. HFF cells were
infected with either strain for 36 h. The samples were fixed and stained using anti-GRA3 antibodies. Serial optical z-sections of about 50 PV randomly
selected were obtained from each strain using fluorescent microscopy. The diameter and length of the PV tubules were measured using Volocity
software. Values shown are means 6 SD of 3 independent infected monolayers for each condition (P values are 0.008 and 0.334 for the diameter and
the length, respectively).
doi:10.1371/journal.ppat.1002410.g015
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hNPC1. After RNA extraction from HFF, the coding sequence
corresponding to the amino acids 1214-1278 of human NPC1 was
amplified by RT-PCR (SuperScript One-Step RT-PCR with
Platinum Taq, Invitrogen) using primers F-hNPC11214-1278 and R-
hNPC11214-1278. The construct TgNCR1D1101-1178 was created by
PCR amplification using F-myc-TgNCR1 1-1101 and R-TgNCR11-
1101. The two fragments were fused by PCR and amplified using
the primers F-myc-TgNCR11-1101 and R-hNCR11214-1278. The
fusion product was then ligated into pcDNA3.1 vector through
EcoRI and HindIII to generate pTgNCR1-hNPC1. In this
plasmid, a myc tag is introduced at the N-terminus of the resulting
protein while the expression of the C-terminal myc tag originally
present in vector pcDNA3.1. was blocked by introducing a stop
codon in the primer R-hNPC1. Using the same cloning strategy, a
plasmid control combining residues 938-1100 of TgNCR1 with
residues 1214-1278 of human NPC1 named tr.(truncated)
TgNCR1-hNPC1, was constructed with a N-terminal myc tag.
Figure 16. Detection of membranous connections between the PV of TgNCR1-deficient parasites in different cells. A. IFA on HFF
infected with either the DNCR1 or parental strain 36 h p.i. using anti-GRA7 antibodies illustrating the connection of two PV in different cells mediated
by membranous extensions. B. IFA on HFF infected with the DNCR1 strain 24 h p.i. using anti-GRA7 antibodies showing different views of PV
connected to each other in the same cells (panels a–c) or neighboring cells (panels d–f). n, host nucleus.
doi:10.1371/journal.ppat.1002410.g016
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myc-TgNCR1938-1100, F-hNPC11214-1278 and R-hNPC11214-1278.
For expression analysis in mammalian cells, cells were transfected
with the different plasmids using lipofectamine method (Invitro-
gen).
Plasmid construction for expression in Toxoplasma
To generate a strain of T. gondii stably expressing TgNCR1
wild-type or mutants with a HA tag at the N-terminus, we used the
backbone of the parasite expression vector psagCATsag_Tu-
b2358YFP obtained from the Roos laboratory (University of
Pennsylvania) to construct pHA-TgNCR1. The TgNCR1 se-
quence was modified by PCR using the primers F-HA-TgNCR1
that contains the coding sequence of an HA tag for expression at
the N-terminus and R-YFP-TgNCR1 that includes a stop codon
to block the translation of the downstream YFP. Same approach
was used for the construction of four plasmids harboring punctual
mutations in the TgNCR1 sequence. The mutations of the
targeted residues were carried out by fusion PCR. Two flanking
primers were F- HA-TgNCR1 and R-YFP-TgNCR1, and the
internal primers used were: F-TgNCR1D571N and R-Tg
NCR1D571N to generate pHA-TgNCR1D571N; F-TgNCR1P913A
and R-TgNCR1P913A for pHA-TgNCR1P913A; F-TgNCR1I957T
and R-TgNCR1I957T for pHA-TgNCR1I957T; F-TgNCR1L1100V
and R-TgNCR1L1100V for pHA-TgNCR1L1100V. To create a
strain of T. gondii transiently expressing TgNCR1 with a HA tag
at the N-terminus under the NTPase promotor, we used the
backbone of the parasite expression vector pRab5-HA containing
the nucleoside triphosphatase III (NTPase III) promoter obtained
from the Joiner laboratory (Yale University). The coding sequence
of TgNCR1 was PCR-amplified using the primers F-haNTP and
R-haNTP. The resulting PCR fragment was digested with SpeI
and PacI, and directly ligated into the NheI and PacI sites of the
pRab5-HA vector. In this construct, TgNCR1 was cloned in
frame with the upstream HA tag coding sequence in the vector.
To generate a strain of T. gondii transiently expressing TgNCR1
with a HA tag at the C-terminus under the tubulin promotor, the
TgNCR1 sequence was modified by PCR using the primers F-
NCRHA and R-NCRHA. The resulting PCR was digested by
BamHI and AvrII and ligated into the BglII and AvrII sites of the
sagCATsag_Tub2358YFP vector. The reverse primer contained
the coding sequence of HA tag followed by a stop codon to block
the translation of the downstream YFP tag. For transient
transfection in T. gondii, expression plasmids containing
TgNCR1coding sequences, wild-type or mutants, were trans-
formed in E. coli DH-5a and isolated using Qiagen Plasmid
Purification Kits. Parasites were transfected by electroporation as
described [6].
Genetic disruption of TgNCR1 gene
To create the DNCR1 strain, a fusion PCR knockout construct
was generated, consisting of 39 and 59NCR1 genomic flanks fused
on either site of the hypoxanthine-xanthine-guanine phosphor-
ibosyltransferase (HXGPRT) selectable marker cassette (Figure
S9). Genomic flanking sequences of the TgNCR1 gene were
obtained from the Toxoplasma database (www.toxodb.org; version
4.3). Primers were designed to amplify ,550-bp of each of the two
flanking regions from the genomic DNA of the RH strain of
Toxoplasma. Two flanks were amplified to overlap on one end with
the HXGPRT selectable marker cassette, and similarly, the
Figure 17. Growth features of TgNCR1-deficient parasites in vivo. Virulence assays of TgNCR1-deficient parasites. 5610
4 parasites of the
DNCR1 or parental strains were intraperitoneally injected into four BALB/c mice per group. Data shown are means of 3 separate assays with ,5%
variation (S.D.).
doi:10.1371/journal.ppat.1002410.g017
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plasmid to incorporate the TgNCR1 sequence on the other end.
The three individual fragments corresponding to 59 flank, 39 flank
and HXGPRT were obtained by PCR reactions using primers
KOPCR-1 and KOPCR-4, KOPCR-5 and KOPCR-2, KOPCR-
3 and KOPCR-6, respectively. The three PCR fragments were
then used as template to generate the fusion construct using
primers KOPCR-1 and KOPCR-2 as shown in Figure 5. Deletion
of TgNCR1 from the parasite genome and HXGPRT arrangement
were verified by PCR and Southern blot analyses. For PCR
confirmation, genomic DNA was isolated from the colonies
obtained through selection and used as template for PCR.
Replacement of TgNCR1 by HXGPRT was monitored using a
primer outside the 59 genomic flanking region (P1) and a primer
within the selectable marker HXGPRT (P2). The primer pairs P3-
P4 and P5-P6 were used to assert the absence of TgNCR1/the
presence of a single copy of HXGPRT in the DNCR1 strain and
the presence of TgNCR1/the absence of HXGPRT in the
DKu80DHXGPRT (DK80) parental strain [71], respectively.
For Southern blotting, the primers F-NPC-sb-1 and R-NPC-sb-1
were used in the PCR to generate a ,0.9-kb probe specific for the
HXGPRT gene. Genomic DNA samples (80 mg) were digested with
AgeI and electrophoresed through 0.7% agarose gels. The DNA
was then transferred onto a Hybond N
+ membrane (Biotech) and
hybridized randomly with the
32P-labeled DNA probe. Blots were
then washed at appropriate stringency and visualized by
autoradiography.
Selection of parasite stable lines
For the generation of the DNCR1 strain, fusion PCR products
(15–20 mg) containing 59 UTR of TgNCR1 gene, HXGPRT
cassette and 39 UTR of TgNCR1 gene were electroporated into the
parasite DKu80 strain [71] as described [6]. After overnight
growth, transformants were placed under 25 mg/ml of mycophe-
nolic acid and 50 mg/ml of xanthine. Transformant pools were
tested by PCR to validate the deletion of NCR1 in parasites, and
TgNCR1 knockout parasites were further selected by limiting
dilution under drug selection. Individual knockout clones were
then plated in 96-well plates and cultivate to ensure clonality.
Fusion PCR construct for complementation
To create the construct for the complementation of the DNCR1
strain, the same fusion PCR approach shown in Figure S9 was
used. Two fragments, 59 and 39 flanking sequences of the NCR1
gene, were amplified using the primers KOPCR-1 and Ncomp-4,
Ncomp-5 and KOPCR-2, respectively, to overlap on one end with
the TgNCR1 coding sequence. The third fragment, TgNCR1
coding sequence, was amplified using primers Ncomp-3 and
Ncomp-6. The three PCR fragments were then used as template
to generate the fusion construct using the primers KOPCR-1 and
KOPCR-2.
Negative selection of HXGPRT with 2-hydroxy-6-
mercaptopurine
For the complementation of the DNCR1 strain, 25 mg of the
fusion PCR product was electroporated into the DNCR1 strain.
Twenty four hours post-transfection, the culture media of
transformants was replaced with DMEM containing HEPES
and 1% dialyzed FBS, and the tranformants were placed under
the selection of 0.85 mg/ml of 2-hydroxy-6-mercaptopurine. Drug
resistant transformant pools were tested by PCR to validate the
replacement of HXGPRT with NCR1 in parasites, and NCR1-
complemented parasites were further selected by limiting dilution
in 96-well plates. Clones were then tested using drug selection to
ensure that they grow in 2-hydroxy-6-mercaptopurine but no
longer in mycophenolic acid and xanthine. After the selection, the
59 integration of TgNCR1 coding sequence was confirmed by
PCR using the pair of primers P1-P7, and the 39integration was
verified by PCR using the pair of primers P8-P9.
Recombinant peptide expression in E. coli and affinity
purification
To generate antibodies against TgNCR1, we engineered a
plasmid to produce a recombinant peptide corresponding to the
sequence of TgNCR1162-501. The coding sequence corresponding
to TgNCR1162-501 was PCR-amplified using the primers F-
TgNCR1162-501 and R-TgNCR1162-501 and directly cloned into
the BamHI and HindIII sites of the pQE-30 vector (Qiagen,
Hilden, Germany) to generate N-terminal 6-His tagged fusion
protein. The recombinant peptide expressed in E. coli M15 strain
were purified under denatured condition on Ni
2+-NTA resin
according to the Qiagen protocol. After purification, the peptide
was refolded by diluting the sample 10 times in the refolding buffer
(50 mM Tris/HCl pH 7.5, 1 mM EDTA, 1 M L-arginine, 1 mM
reduced form of glutathione, 0.8 mM of oxidized form of
glutathione) at 4uC overnight before concentration and dialysis
against phosphate-buffered saline (PBS). Some batches of
antibodies against TgNCR1162-501 were further preadsorbed on
a fibroblast lysate (overnight, 4uC) to diminish unspecific cross-
reactions between the primary antibody and host cell epitopes.
Immunoblot analysis of parasites stably expressing
HA-TgNCR1
For immunodetection, transgenic parasites were lysed in the M-
PER mammalian protein extraction reagent (Pierce Biotechnology,
Rockford, IL). The cell extracts were suspended in SDS gel-loading
buffer (50 mM Tris–HCl (pH 6.8), 50 mM 2-mercaptoethanol, 2%
SDS,0.1%bromophenolblue,10%glycerol)and lysedbyboilingin
a water bath. The samples were subjected to SDS-PAGE, and the
proteins were then electrophoretically transferred to a membrane
(Immobilon Transfer Membranes, Millipore, Bedford, MA). The
membrane was immersed in blocking buffer (PBS containing 3%
skim milk) for 60 min, and then incubated with anti-HA antibody
(1:5000) in the blocking buffer for 60 min. Unbound antibody was
removed by washing the membrane six times with blocking buffer.
Next, the membrane was incubated with horseradish peroxidase-
conjugated goat anti-mouse IgG antibody (Amersham Pharmacia
Biotech; dilution, 1:1000) in blocking buffer for an additional hour,
before detection by chemiluminescence.
Cell cycle analysis
Vero cells were infected with either the DNCR1 or parental
strain at the M.O.I of 10 and washed every 2 h p.i. to synchronize
the infection. Fifteen hours p.i., infected cells were exposed to the
calcium ionophore A23187 at 4 mM for 10 min to induce parasites
egress. Parasites in the supernatant were collected by aspiration,
washed by centrifugation and fixed in ice-cold ethanol (70%),
followed by incubation with propidium iodide (PI) solution
(0.01 mg/ml PI; 0.01 mg/ml DNAse-free RNAse A; 0.1% Triton
X-100; 1 mg/ml sodium citrate) at 4uC overnight. Uninfected
VERO cells as controls were treated similarly to infected cells.
Flow cytometry analysis was performed on a FACScan flow
cytometer (Becton Dickinson, Mountain View, CA). Cell cycle
distribution pattern was assessed using FlowJo software (Tree Star,
Inc.); G1, G2 and S peaks were defined using the Dean-Jet-Fox
model.
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5 week-old female BALB/C mice were purchased from The
Jackson Laboratory (Bar Harbor, ME). Groups of six mice were
infected intraperitoneally with 5610
4 tachyzoites of DNCR1 or
DKu80DHXGPRT parasites. The survival of mice after infection
was monitored daily. Results of three independent experiments are
presented.
Measurement of lipids
Thin layer chromatography (TLC). Total lipids from
mammalian cells were extracted in chloroform/methanol (v/v,
2:1), subsequently separated by TLC on silica plates using
hexane:diethyl ether:acetic acid (v/v/v, 90:10:1) for free
cholesterol and cholesteryl esters, or using chloroform:
methanol:0.2% CaCl2 (v/v/v/, 60:35:8) for gangliosides, and
visualized as described [31].
Mass spectrometry. Total lipids from the DNCR1 and
parental strains were extracted using a modified Bligh and Dyer
procedure as described [72]. Purified standards of lipids were
added directly to homogenates. Mass spectrometry analyses of
species of cholesterol, cholesteryl esters, triglycerides, sphingolipids
and phospholipids were performed using a Sciex API 3000 triple
stage quadruple tandem mass spectrometer (ESI/MS/MS) from
Sciex Inc. (Thornhill, Ontario, Canada), using methods similar to
those described in previous studies [72,73]. Peaks were evaluated
with non-parametric one-way ANOVA (Kruskal-Wallis test, with
a threshold of P-value ,0.05 considered as statistically significant.
Light and electron microscopy studies
Light and epifluorescence microscopy were performed on
infected cells seeded on sterile coverslips in 24-well culture dishes.
IFA on parasites or mammalian cells were performed as previously
described [56] usingprimaryantibodies against GRA3 (1:100), anti-
GRA7 (1:100), myc (1:100), HA (1:1000), EEA1 (1:100), LAMP1
(1:100), and secondary antibodies (Invitrogen): anti-mouse and anti-
rabbit IgG antibodies conjugated to either Alexa 488 or Alexa 594
diluted at 1:2000. For detection of cholesterol or lipid bodies by
fluorescence microscopy, intravacuolar parasites were fixed in
paraformaldehyde, and treated as described [2,56]. Slides were
observed using a Nikon Eclipse E800 microscope equipped with a
Spot RT CCD Camera and processed using Image-Pro-Plus
software (Media Cybernetics, Silver Spring, MD) before assembly
using Adobe Photoshop (Adobe Systems, Mountain View, CA). For
analysis of PV membranous extensions, HFF were infected with
either the DNCR1 or DHXGPRT stain for 36-h. After fixation and
immunostaining for GRA7 and GRA3, parasites were imaged with
a fluorescent microscope (Nikon 90i) using a Plan-Apochromat
100x/1.4 NA. Serial optical z-sections were acquired with a
Hammatsu camera and Volocity software (Improvision, Waltham,
MA). Using the Volocity software, images were processed by
iterative restoration (deconvolution algorithm) and the length and
diameter of the PV membranous extensions, as detected by GRA3
staining, were measured. To quantify the levels of filipin
accumulation, images were collected using sequential scanning,
processed and merged using Volocity software. For ultrastructural
observation of the DNCR1 strain by thin-section transmission
electron microscopy (EM), infected cells were fixed in 2.5%
glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA) and
processed as described [56]. Ultrathin sections of infected cells were
stained before examination with a Philips CM120 EM (Eindhoven,
the Netherlands) under 80 kV. For immunoelectron microscopy,
Toxoplasma-infected cells were fixed in 4% paraformaldehyde
(Electron Microscopy Sciences) and processed as previously
described [38]. The sections were immunolabeled with anti-HA
antibodies (1:200 in PBS/1% fish skin gelatin), then with mouse
anti-mouse IgG antibodies, followed directly by 10 nm protein A-
gold particles(Department ofCellBiology, Medical School, Utrecht
University, the Netherlands) before microscopic examination.
Protein determination
Protein content was determined using the bicinchoninic acid
assay [74] with serum bovine albumin (BSA) as a standard.
Supporting Information
Figure S1 Predicted ORF of TgME49_090870 from T. gondii.
The sterol-sensing-like domain is underlined in red. Potential
transmembrane segments (according to the transmembrane folding
program: http://liao.cis.udel.edu/website/servers/TMMOD/scri
pts/frame.php?p=description) are shown in yellow while putative
N-glycosylation sites (according to the NetNGLyc 1.0 server) are in
blue.
(PDF)
Figure S2 Phylogeny of NPC1-related proteins in the indicated
organisms. The EuPath database version 2.10 was searched using
the blastp tool with the protein sequence of TGME49_090870
(full-length) to identify NPC1-related proteins among the eukary-
otic pathogens of the genera Cryptosporidium, Giardia, Leishmania,
Neospora, Plasmodium, Toxoplasma, Trichomonas and Trypanosoma.
Many Apicomplexa have one or two NPC1-like proteins. Among
other protozoa, Entamoeba species have a NPC1-related protein,
which shows close phylogeny to yeast, human and helminth NPC1
homologs. No NPC1-like gene was present in Flagellates (e.g.,
Trypanosoma, Leishmania and Giardia). The resulting full-length
sequences were aligned using ClustalW (scoring matrix=Blosum;
gap open penalty=10; end gap penalty=10; gap extension
penalty=0.5; separation gap penalty=0.05). We have calculated
an unrooted phylogenic tree according to the program Jalview
2.6.1 [22] by neighbor joining using percent identity.
(PDF)
Figure S3 Predicted transmembrane regions within the SSD of
the indicated proteins. Multiple sequence alignment of the
predicted SSD of TGME49_090870 with the human sequences
of NPC1 (GI:38649260), Patched (GI:1381236) and SCAP
(GI:66932902) using the CLUSTALW program. The five
successive transmembrane domains are indicated in color.
(PDF)
Figure S4 Characterization of the 2-2 mutant CHO cell line. A.
Fluorescence microscopy of the cells labeled with the filipin dye
showing bright punctate structures resulting from the accumula-
tion of cholesterol in endo-lysosomes. B. EM at high magnification
of these cells showing cholesterol deposits as electron-dense
materials in the overloaded lysosomes.
(PDF)
Figure S5 Cholesteryl ester (CE) levels in the mammalian
NPC1-mutant cells expressing TgNCR1-hNPC1. Quantitative
TLC analysis of neutral fraction of cellular lipid extracts from
CHO wild-type cells or mutants transfected with either the vector
only or TgNCR1-hNPC1. No significant differences in CE levels
were detected between the 3 conditions (n=3 independent assays).
(PDF)
Figure S6 Coomassie blue-stained gel showing the 38-kDa
recombinant peptide from TgNCR1 after purification from E. coli
extracts. The peptide was used to produce antibodies against
TgNCR1.
(PDF)
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gondii. IFA of intracellular parasites using anti-TgNCR1162-501
antibodies (dilution 1/5) showing a peripheral fluorescence signal
on the parasites forming small or large PV. Arrows in red pinpoint
stained structures that are suggestive for the inner membrane
complex, which is located beneath the plasma membrane.
(PDF)
Figure S8 Localization of TgNCR1 in parasites transiently
expressing either HA-TgNCR1or TgNCR1-HA. Immunofluores-
cence assays using anti-HA antibodies on parasites transiently
transfected with a plasmid containing HA-TgNCR1 under the
NTPase promoter (A) or HA-TgNCR1-HA under the tubulin
promoter (B) showing IMC labeling 16 h to 24 h p.i.
(PDF)
Figure S9 Schematic showing the NCR1 knockout strategy.
Double homologous recombination results in the replacement of
NCR1 with the selectable marker HXGPRT. NCR1 59 and 39
genomic flanking regions were amplified with sequences overlap-
ping the dhfr-HXGPRT-dhfr selectable marker while the
selectable marker was amplified to contain overlaps with the
NCR1 genomic flanking regions. Using fusion PCR, a DNCR1
product was created containing the genomic flanking regions of
NCR1 on either side of the selectable marker. Double homologous
recombination was used to replace NCR1 with HXGPRT.
(PDF)
Figure S10 Transmission EM of the DNCR1 strain infecting
HFF for 48 h. Knockout parasites formed large rosettes within
their PV similarly to the parental strain. Note the association of
host mitochondria (hm) with the PV membrane and the retention
of residual bodies (RB). Arrowheads show IMC profiles. Bar is
2 mm. The inset shows a phase-contrast image by light microscopy
of the DNCR1 strain.
(PDF)
Figure S11 Complementation of the DNPC1 strain with
NCR1from Toxoplasma. Top: schematic showing the two primer
sets used to verify the insertion of NCR1 into the DNCR1 strain.
The 59 integration of NCR1 coding sequence was confirmed by
PCR analysis using P1 and P7, and the 39 integration by PCR
using P8 and P9.
(PDF)
Figure S12 Ultrastructural observations of TgNCR1-deficient
parasites. Transmission EM of TgNCR1-deficient parasites
infecting HFF for 24 h. A. Replicating parasites were frequently
observed for the DNCR1 strain, indicative of synchronous
division. Images from panel a to g illustrate progressive views of
parasite endodyogeny, presenting similarities with wild-type
parasites. Arrows pinpoint IMC scaffolds. a, apicoplast; Go,
Golgi; m, mitochondrion; mi, micronemes; n, nucleus; r, rhoptries.
Bars are 1 mm.
(PDF)
Figure S13 Demonstration of tubular extensions from the PV of
wild-type parasites (RH strain). Immunofluorescence assays using
anti-GRA7 antibodies on Toxoplasma-infected cells after 24 h. Note
the presence of at least three PV membrane extensions into the
host cytosol.
(PDF)
Table S1 Analysis of phospholipid composition in the DNCR1
and parental strains by mass spectrometry. Quantitative analysis of
MRM spectra from the DNCR1 and parental strains showing
levels of various species of phospholipids. Statistically significant
differences in the amounts of few species of phosphatidylethanol-
amine and phosphatidylserine were detected in TgNCR1-deficient
parasites. Data are cps means 6 SD from 3 independent
populations from each strain.
(PDF)
Table S2 Primers used in this study.
(PDF)
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